- Ashok Leyland‘s vehicle sales for November 2025 were reported at 18,272 units.
- This represents a 29% increase in sales compared to previous periods.
- Out of the total sales, 16,491 units were sold domestically.
- Market analysts’ recommendations for Ashok Leyland include 34 “buy” ratings.
- The company received 7 “hold” recommendations from analysts.
- There are 4 “sell” ratings from market analysts for Ashok Leyland.
A look at Ashok Leyland Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 5 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Ashok Leyland appears to have a promising long-term outlook. The company scores high in Dividend, Growth, and Momentum, indicating strong performance in these areas. With a focus on dividends and growth, Ashok Leyland seems to be well-positioned for future success in the market. Additionally, the company’s resilience score of 3 suggests a moderate ability to withstand economic challenges, further bolstering its potential for long-term sustainability.
Ashok Leyland Limited, a manufacturer of commercial vehicles and industrial products, shows solid potential for growth and stability in the long run. Its high scores in Dividend and Growth reflect a promising future, while strong Momentum indicates positive market momentum. Despite a moderate Resilience score, the company’s diversified product range and international presence bode well for its ability to adapt to changing market conditions. Overall, Ashok Leyland‘s outlook appears positive, supported by its strong performance in key areas.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
